Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02584400 : Tumor Hypoxia With HX4 PET in Several Diseases
PhasePhase 2
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Histological/cytological confirmed carcinoma of de esophagus, rectum or prostate or
radiological suspicion for Grade IV glioma (primary brain tumor) or brain metastases

- WHO performance status 0 to 2.

- Adequate renal function (calculated creatinine clearance at least 60 ml/min).

- The patient is willing and capable to comply with study procedures

- 18 years or older

- Have given written informed consent before patient registration

Exclusion Criteria:

- Recent (< 3 months) myocardial infarction

- Pregnant or breast feeding and willing to take adequate contraceptive measures during
the study
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02584400      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740